Vaccination with an in vitro culture attenuated Babesia bovis strain safely protects highly susceptible adult cattle against acute bovine babesiosis

• Published in: Frontiers in immunology 2023-07, Vol.14, p.1219913-1219913
• Main Authors: Bastos, Reginaldo G., Capelli-Peixoto, Janaina, Laughery, Jacob M., Suarez, Carlos E., Ueti, Massaro W.
• Format: Article
• Language: English
• Subjects: Babesia bovis; Babesia immunity; Babesia vaccine; bovine babesiosis; Immunology; in vitro culture attenuated vaccines
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2023.1219913

IntroductionLive in vivo attenuated Babesia bovis vaccines produced by sequential passages in splenectomized calves have historically been used to control acute bovine babesiosis in endemic areas worldwide. However, several constraints prevent the widespread use of these vaccines, including the need for several splenectomized calves to produce vaccine batches, and potential inconsistent parasite attenuation, which contraindicates their use for highly Babesia-susceptible adult cattle. Thus, the use of vaccines based on well-defined in vitro culture attenuated B. bovis strains emerges as a more sustainable and efficient alternative. Previous work demonstrated that the culture attenuated strain Att-S74-T3Bo is non-tick transmissible and able to safely protect calves against needle challenge with a B. bovis virulent strain. Methods and resultsHerein we evaluated safety and efficacy of Att-S74-T3Bo in preventing acute babesiosis in adult (>1.5 year of age) cattle. Results demonstrated that Att-S74-T3Bo vaccination of adult animals (n=5) induced self-limiting signs of acute infection and protected the vaccinated animals against challenge with the homologous virulent B. bovis strain Vir-S74-T3Bo. Att-S74-T3Bo-vaccinated adult cattle developed significant (P